PSMC6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.250400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.332400E-01
Normal-vs-Stage2
9.938400E-01
Normal-vs-Stage3
3.685600E-01
Normal-vs-Stage4
7.881600E-01
Stage1-vs-Stage2
2.877800E-01
Stage1-vs-Stage3
6.797800E-01
Stage1-vs-Stage4
3.757200E-01
Stage2-vs-Stage3
1.557750E-01
Stage2-vs-Stage4
6.777600E-01
Stage3-vs-Stage4
3.819200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.176200E-01
Normal-vs-AfricanAmerican
5.515400E-01
Normal-vs-Asian
4.491600E-01
Caucasian-vs-AfricanAmerican
5.878200E-01
Caucasian-vs-Asian
4.570200E-01
AfricanAmerican-vs-Asian
9.880600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.787200E-01
Normal-vs-Female
5.664200E-01
Male-vs-Female
5.986600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.022600E-01
Normal-vs-Age(41-60Yrs)
3.170000E-02
Normal-vs-Age(61-80Yrs)
9.598200E-02
Normal-vs-Age(81-100Yrs)
9.067000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.160200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.709600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.717600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.675410E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.379800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.921400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.413000E-01
Normal-vs-Daily Drinker
4.029400E-01
Normal-vs-Weekly Drinker
2.487000E-01
Normal-vs-Occasional Drinker
2.522600E-01
Normal-vs-Social Drinker
5.988000E-01
Non Drinker-vs-Daily Drinker
8.050600E-01
Non Drinker-vs-Weekly Drinker
4.569800E-01
Non Drinker-vs-Occasional Drinker
3.003700E-02
Non Drinker-vs-Social Drinker
7.854800E-01
Daily Drinker-vs-Weekly Drinker
6.133800E-01
Daily Drinker-vs-Occasional Drinker
2.147800E-02
Daily Drinker-vs-Social Drinker
9.803800E-01
Weekly Drinker-vs-Occasional Drinker
1.327840E-02
Weekly Drinker-vs-Social Drinker
6.122600E-01
Occasional Drinker-vs-Social Drinker
6.142400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.453600E-01
Normal-vs-Grade 2
5.861600E-01
Normal-vs-Grade 3
5.433000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.098800E-01
Grade 1-vs-Grade 3
5.609900E-02
Grade 1-vs-Grade 4
6.453600E-01
Grade 2-vs-Grade 3
2.045400E-01
Grade 2-vs-Grade 4
5.861600E-01
Grade 3-vs-Grade 4
5.433000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.663400E-01
Normal-vs-NonDiabetic
9.468800E-01
Diabetic-vs-NonDiabetic
3.077400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.919800E-02
Normal-vs-NoPancreatitis
8.288800E-01
Pancreatitis-vs-NoPancreatitis
1.491240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.166800E-01
Normal-vs-N1
9.310000E-01
N0-vs-N1
4.630800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.633800E-02
Normal-vs-TP53-NonMutant
1.637590E-01
TP53-Mutant-vs-TP53-NonMutant
2.20689999999024E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
